156 related articles for article (PubMed ID: 11387039)
1. Characterizing glycosylation pathways.
Yarema KJ; Bertozzi CR
Genome Biol; 2001; 2(5):REVIEWS0004. PubMed ID: 11387039
[TBL] [Abstract][Full Text] [Related]
2. Genetic defects in the hexosamine and sialic acid biosynthesis pathway.
Willems AP; van Engelen BG; Lefeber DJ
Biochim Biophys Acta; 2016 Aug; 1860(8):1640-54. PubMed ID: 26721333
[TBL] [Abstract][Full Text] [Related]
3. Metabolic selection of glycosylation defects in human cells.
Yarema KJ; Goon S; Bertozzi CR
Nat Biotechnol; 2001 Jun; 19(6):553-8. PubMed ID: 11385460
[TBL] [Abstract][Full Text] [Related]
4. Ethanol impairs monosaccharide uptake and glycosylation in cultured rat astrocytes.
Tomás M; Fornas E; Megías L; Durán JM; Portolés M; Guerri C; Egea G; Renau-Piqueras J
J Neurochem; 2002 Nov; 83(3):601-12. PubMed ID: 12390522
[TBL] [Abstract][Full Text] [Related]
5. Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.
Badr HA; AlSadek DM; Mathew MP; Li CZ; Djansugurova LB; Yarema KJ; Ahmed H
Biomaterials; 2015 Nov; 70():23-36. PubMed ID: 26295436
[TBL] [Abstract][Full Text] [Related]
6. Histochemistry of lectin-binding sites in Halicryptus spinulosus (Priapulida).
Busch A; Schumacher U; Storch V
Acta Histochem; 2001 Feb; 103(1):9-19. PubMed ID: 11252632
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of glycosylation by stable co-expression of two sialylation-related enzymes on Chinese hamster ovary cells.
Thi Sam N; Misaki R; Ohashi T; Fujiyama K
J Biosci Bioeng; 2018 Jul; 126(1):102-110. PubMed ID: 29439861
[TBL] [Abstract][Full Text] [Related]
8. Glycoengineering the N-acyl side chain of sialic acid of human erythropoietin affects its resistance to sialidase.
Werner A; Horstkorte R; Glanz D; Biskup K; Blanchard V; Berger M; Bork K
Biol Chem; 2012 Aug; 393(8):777-83. PubMed ID: 22944680
[TBL] [Abstract][Full Text] [Related]
9. Siglecs: a family of sialic-acid binding lectins.
Crocker PR; Clark EA; Filbin M; Gordon S; Jones Y; Kehrl JH; Kelm S; Le Douarin N; Powell L; Roder J; Schnaar RL; Sgroi DC; Stamenkovic K; Schauer R; Schachner M; van den Berg TK; van der Merwe PA; Watt SM; Varki A
Glycobiology; 1998 Feb; 8(2):v. PubMed ID: 9498912
[No Abstract] [Full Text] [Related]
10. On the differential sialic acid specificity of lectins from different parts of Saraca indica.
Chatterjee BP; Majumder M
Adv Exp Med Biol; 2011; 705():213-28. PubMed ID: 21618110
[No Abstract] [Full Text] [Related]
11. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
12. Engineered carbohydrate-recognition domains for glycoproteomic analysis of cell surface glycosylation and ligands for glycan-binding receptors.
Powlesland AS; Quintero-Martinez A; Lim PG; Pipirou Z; Taylor ME; Drickamer K
Methods Enzymol; 2010; 480():165-79. PubMed ID: 20816210
[TBL] [Abstract][Full Text] [Related]
13. CDG: a new case of a combined defect in the biosynthesis of N- and O-glycans.
Albahri Z; Marklová E; Dedek P; Hojdíková H; Fiedler Z; Lefeber D; Wevers RA; Morava E; Wopereis S
Eur J Pediatr; 2006 Mar; 165(3):203-4. PubMed ID: 16416133
[No Abstract] [Full Text] [Related]
14. Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor.
Kaneko MK; Kato Y; Kameyama A; Ito H; Kuno A; Hirabayashi J; Kubota T; Amano K; Chiba Y; Hasegawa Y; Sasagawa I; Mishima K; Narimatsu H
FEBS Lett; 2007 Jan; 581(2):331-6. PubMed ID: 17222411
[TBL] [Abstract][Full Text] [Related]
15. Cell surface glycoproteins from Thermoplasma acidophilum are modified with an N-linked glycan containing 6-C-sulfofucose.
Vinogradov E; Deschatelets L; Lamoureux M; Patel GB; Tremblay TL; Robotham A; Goneau MF; Cummings-Lorbetskie C; Watson DC; Brisson JR; Kelly JF; Gilbert M
Glycobiology; 2012 Sep; 22(9):1256-67. PubMed ID: 22692048
[TBL] [Abstract][Full Text] [Related]
16. Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
Amano M; Eriksson H; Manning JC; Detjen KM; André S; Nishimura S; Lehtiö J; Gabius HJ
FEBS J; 2012 Nov; 279(21):4062-80. PubMed ID: 22943525
[TBL] [Abstract][Full Text] [Related]
17. Altered glycosylation of membrane glycoproteins associated with human mammary carcinoma.
Hiraizumi S; Takasaki S; Ohuchi N; Harada Y; Nose M; Mori S; Kobata A
Jpn J Cancer Res; 1992 Oct; 83(10):1063-72. PubMed ID: 1452459
[TBL] [Abstract][Full Text] [Related]
18. From glycosylation disorders back to glycosylation: what have we learned?
Hennet T
Biochim Biophys Acta; 2009 Sep; 1792(9):921-4. PubMed ID: 19007883
[TBL] [Abstract][Full Text] [Related]
19. Altered glycan structures: the molecular basis of congenital disorders of glycosylation.
Freeze HH; Aebi M
Curr Opin Struct Biol; 2005 Oct; 15(5):490-8. PubMed ID: 16154350
[TBL] [Abstract][Full Text] [Related]
20. Significance of glycosylation patterns of rat Zajdela ascitic hepatocellular carcinoma: effect of enzymatic removal of surface sialic acid on humoral response.
Sudhakar C; Mangamoori LN
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e283-9. PubMed ID: 18702685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
